Singh SK. ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY. SJHR-Africa [Internet]. 7 decembrie 2023 [citat 12 septembrie 2026];4(12):5. Disponibil la: https://www.sjhrafrica.org.sjhresearchafrica.org/index.php/public-html/article/view/865